Enanta Pharmaceuticals Net Profit Margin 2011-2019 | ENTA

Enanta Pharmaceuticals net profit margin from 2011 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Enanta Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-03-31 $0.23B $0.08B 32.91%
2018-12-31 $0.24B $0.09B 36.13%
2018-09-30 $0.21B $0.07B 34.95%
2018-06-30 $0.22B $0.08B 38.14%
2018-03-31 $0.17B $0.05B 32.53%
2017-12-31 $0.13B $0.04B 27.48%
2017-09-30 $0.10B $0.02B 18.45%
2017-06-30 $0.04B $-0.02B -50.00%
2017-03-31 $0.05B $-0.01B -28.26%
2016-12-31 $0.05B $-0.01B -20.00%
2016-09-30 $0.09B $0.02B 23.86%
2016-06-30 $0.09B $0.03B 32.58%
2016-03-31 $0.09B $0.03B 36.78%
2015-12-31 $0.13B $0.06B 48.09%
2015-09-30 $0.16B $0.08B 49.38%
2015-06-30 $0.15B $0.07B 45.64%
2015-03-31 $0.18B $0.12B 64.80%
2014-12-31 $0.12B $0.08B 66.13%
2014-09-30 $0.05B $0.04B 72.92%
2014-06-30 $0.05B $0.04B 78.26%
2014-03-31 $0.01B $-0.02B -300.00%
2013-12-31 $0.01B $-0.02B -360.00%
2013-09-30 $0.03B $-0.01B -34.38%
2013-06-30 $0.03B $-0.01B -36.36%
2013-03-31 $0.03B $-0.01B -38.24%
2012-12-31 $0.07B $-0.01B -7.14%
2012-09-30 $0.04B $-0.01B -16.67%
2012-06-30 $0.04B $-0.00B -5.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.838B $0.207B
Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $49.273B 31.48
Takeda Pharmaceutical (TAK) Japan $27.310B 8.02
Grifols (GRFS) Spain $12.644B 15.99
Ionis Pharmaceuticals (IONS) United States $9.621B 21.03
Sage Therapeutics (SAGE) United States $8.999B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.985B 10.94
Neurocrine Biosciences (NBIX) United States $7.284B 0.00
Catalent (CTLT) United States $6.729B 27.01
Nektar Therapeutics (NKTR) United States $5.834B 9.51
Tilray (TLRY) Canada $4.476B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.018B 14.10
United Therapeutics (UTHR) United States $3.814B 0.00
FibroGen (FGEN) United States $3.071B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.578B 9.28
PTC Therapeutics (PTCT) United States $2.360B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.066B 311.29
Portola Pharmaceuticals (PTLA) United States $1.962B 0.00
Xencor (XNCR) United States $1.884B 51.45
Tricida (TCDA) United States $1.846B 0.00
Aerie Pharmaceuticals (AERI) United States $1.842B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.795B 86.92
USANA Health Sciences (USNA) United States $1.765B 15.34
Ironwood Pharmaceuticals (IRWD) United States $1.751B 0.00
Zogenix (ZGNX) United States $1.656B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.521B 0.00
Endo (ENDP) Ireland $1.429B 2.30
Heron Therapeutics (HRTX) United States $1.389B 0.00
Esperion Therapeutics (ESPR) United States $1.374B 0.00
Corcept Therapeutics (CORT) United States $1.172B 16.72
TURNING PT THER (TPTX) United States $1.147B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.078B 0.00
Radius Health (RDUS) United States $0.942B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.862B 0.00
ArQule (ARQL) United States $0.788B 0.00
TherapeuticsMD (TXMD) United States $0.767B 0.00
Aptorum Group (APM) China $0.715B 0.00
ChemoCentryx (CCXI) United States $0.684B 0.00
Akebia Therapeutics (AKBA) United States $0.656B 0.00
ORGANOGENESIS (ORGO) United States $0.647B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.640B 0.00
CannTrust Holdings (CTST) Canada $0.623B 0.00
Odonate Therapeutics (ODT) United States $0.603B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.595B 0.00
Dermira (DERM) United States $0.534B 0.00
GlycoMimetics (GLYC) United States $0.513B 0.00
Flexion Therapeutics (FLXN) United States $0.491B 0.00
Siga Technologies (SIGA) United States $0.472B 1.11
Corbus Pharmaceuticals Holdings (CRBP) United States $0.471B 0.00
Translate Bio (TBIO) United States $0.460B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.452B 22.85
Mast Therapeutics (SVRA) United States $0.400B 0.00
KalVista Pharmaceuticals (KALV) United States $0.399B 0.00
Forty Seven (FTSV) United States $0.391B 0.00
Collegium Pharmaceutical (COLL) United States $0.390B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.379B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.365B 0.00
OptiNose (OPTN) United States $0.358B 0.00
Karyopharm Therapeutics (KPTI) United States $0.352B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.343B 0.00
Xeris Pharmaceuticals (XERS) United States $0.336B 0.00
TCR2 Therapeutics (TCRR) United States $0.332B 0.00
CASI Pharmaceuticals (CASI) United States $0.308B 0.00
ImmunoGen (IMGN) United States $0.289B 0.00
Harpoon Therapeutics (HARP) United States $0.283B 0.00
Molecular Templates (MTEM) United States $0.279B 0.00
Dova Pharmaceuticals (DOVA) United States $0.274B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.260B 0.00
Concert Pharmaceuticals (CNCE) United States $0.257B 0.00
Lannett Co Inc (LCI) United States $0.238B 2.31
Aratana Therapeutics (PETX) United States $0.236B 0.00
Calithera Biosciences (CALA) United States $0.233B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.229B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.229B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.224B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.221B 0.00
MEI Pharma (MEIP) United States $0.217B 0.00
Rafael Holdings (RFL) United States $0.215B 0.00
Minerva Neurosciences (NERV) United States $0.211B 0.00
Aclaris Therapeutics (ACRS) United States $0.209B 0.00
Recro Pharma (REPH) United States $0.207B 0.00
Aldeyra Therapeutics (ALDX) United States $0.200B 0.00
IMV INC (IMV) Canada $0.199B 0.00
Opexa Therapeutics (ACER) United States $0.197B 0.00
Galectin Therapeutics (GALT) United States $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.191B 61.88
Ardelyx (ARDX) United States $0.176B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.172B 0.00
Jounce Therapeutics (JNCE) United States $0.167B 0.00
Redhill Biopharma (RDHL) Israel $0.166B 0.00
Majesco Entertainment (PTE) United States $0.163B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.155B 0.00
Tyme Technologies (TYME) United States $0.151B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.141B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.138B 0.00
Neon Therapeutics (NTGN) United States $0.130B 0.00
Bio Blast Pharma (ENLV) Israel $0.120B 0.00
DURECT (DRRX) United States $0.116B 0.00
Aquestive Therapeutics (AQST) United States $0.115B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.115B 0.00
Ocular Therapeutix (OCUL) United States $0.114B 0.00
MediWound (MDWD) Israel $0.112B 0.00
Nivalis Therapeutics (ALPN) United States $0.106B 0.00
ProNAi Therapeutics (SRRA) Canada $0.105B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 71.11
Zafgen (ZFGN) United States $0.099B 0.00
Cardiome Pharma (CORV) Canada $0.099B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
AgeX Therapeutics (AGE) United States $0.097B 0.00
Natural Alternatives (NAII) United States $0.096B 9.62
China SXT Pharmaceuticals (SXTC) China $0.093B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Infinity Pharmaceuticals (INFI) United States $0.084B 0.00
Neos Therapeutics (NEOS) United States $0.083B 0.00
Otonomy (OTIC) United States $0.082B 0.00
Adherex Technologies (FENC) United States $0.082B 0.00
ElectroCore (ECOR) United States $0.080B 0.00
Avenue Therapeutics (ATXI) United States $0.078B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.077B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.070B 0.00
SCYNEXIS (SCYX) United States $0.068B 0.00
Capnia (SLNO) United States $0.065B 0.00
Genocea Biosciences (GNCA) United States $0.063B 0.00
Novan (NOVN) United States $0.060B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.060B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.055B 0.00
CTI BioPharma (CTIC) United States $0.050B 0.00
KemPharm (KMPH) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.047B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.047B 0.00
AIT Therapeutics (AITB) Israel $0.045B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.044B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Bio-Path Holdings (BPTH) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
Lipocine (LPCN) United States $0.038B 0.00
Melinta Therapeutics (MLNT) United States $0.035B 0.00
ContraFect (CFRX) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.033B 0.00
IsoRay (ISR) United States $0.031B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
Regulus Therapeutics (RGLS) United States $0.029B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
HANCOCK JAFFE (HJLI) United States $0.028B 0.00
Achieve Life Sciences (ACHV) United States $0.025B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.023B 2.98
PharmAthene (ALT) United States $0.022B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (SAVA) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Shineco (TYHT) China $0.017B 2.81
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.97
VAXART, INC (VXRT) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.009B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.007B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00